Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Brain Neoplasms 5Prostatic Neoplasms 4Lung Neoplasms 3Glioma 3Carcinoma, Hepatocellular 3Sarcoma 2Pinealoma 2Pancreatic Neoplasms 2Meningioma 2Liver Neoplasms 2Glioblastoma 2Breast Neoplasms 2Urothelial Carcinoma of the Bladder 1Thoracic Neoplasms 1Stage IA-IIA Breast Cancer 1Solid Tumor 1Rhabdomyosarcoma 1Resected Pancreatic Adenocarcinoma 1Recurrence 1Radiation Injuries 1Oligodendroglioma 1Neoplasms 1Nasopharyngeal Carcinoma 1Mesenchymal Tumor 1Medulloblastoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hemangiopericytoma 1Gliosarcoma 1

Interventions

Temozolomide 93Radiotherapy 66Bevacizumab 35Radiation 22Carmustine 21Erlotinib Hydrochloride 17Chemotherapy, Adjuvant 17Irinotecan 16Magnetic Resonance Spectroscopy 13Radiotherapy, Conformal 11O(6)-benzylguanine 11Surgical Procedures, Operative 10Radiotherapy, Intensity-Modulated 10sargramostim 9Sirolimus 9Imatinib Mesylate 9Carboplatin 9temsirolimus 8motexafin gadolinium 7Thalidomide 7Gene Expression Profiling 7aldesleukin 6Sorafenib 6Radiosurgery 6Immunohistochemistry 6Hydroxyurea 6Gefitinib 6Filgrastim 6Everolimus 6Etoposide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gliosarcoma × Proton Therapy × Clear all
NCT01730950 2022-12-29

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 2 Completed
182 enrolled 19 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡